GlassScriptPhysician profile
Ross B Feinman
NPI 1952310807
$4,588.59
in general payments reported to CMS, 2019-2025
29 companies · $1,139 in 2025
The $1,139 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $41.52 · 2021: $331 · 2022: $653 · 2023: $963 · 2024: $961 · 2025: $1,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,062.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,431.23 | 2019-2025 | Ortholoc 3di, Infinity, Anchorage |
| Integra Lifesciences Corporation | $354.02 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Aroa Biosurgery Incorporated | $327.94 | 2023-2025 | |
| Osteomed LLC | $260.78 | 2019-2022 | |
| Bioventus LLC | $239.62 | 2022 | |
| Depuy Synthes Sales INC. | $177.64 | 2025 | Foot Osteotomy Wedge System |
| Urgo Medical North America, LLC | $148.24 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Mimedx Group, INC. | $141.65 | 2025 | |
| Sanara Medtech INC. | $132.49 | 2023 | Celleraterx |
| Progenacare Global, LLC | $131.56 | 2023-2024 | |
| Surgenex LLC | $131.05 | 2025 | Ardeograft, Surgraft, Pellograft |
| Davol INC. | $128.88 | 2025 | Arista |
| Vertex Pharmaceuticals Incorporated | $125.03 | 2025 | |
| Convatec INC. | $125.00 | 2024 | |
| Amgen INC. | $121.35 | 2024 | Krystexxa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $120.91 | 2024 | Restrata Wound Matrix |
| Wright Medical Technology, INC. | $98.81 | 2019 | |
| Organogenesis INC. | $98.80 | 2023 | Puraply Antimicrobial |
| Zimmer Biomet Holdings, INC. | $68.84 | 2019 | |
| Kerecis Limited | $61.27 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Osiris Therapeutics INC. | $35.51 | 2019 | |
| Nestle Healthcare Nutrition INC. | $22.10 | 2021 | |
| Krystal Biotech INC | $19.86 | 2024 | Vyjuvek |
| Exact Sciences Corporation | $18.42 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.14 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $14.39 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.77 | 2023 | Seglentis, Livalo |
| Merck Sharp & Dohme LLC | $12.33 | 2021 | |
| Next Science LLC | $10.96 | 2023 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Feinman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.